430 related articles for article (PubMed ID: 20415685)
1. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
[TBL] [Abstract][Full Text] [Related]
2. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
Finelli C; Tarantino G
World J Gastroenterol; 2013 Feb; 19(6):802-12. PubMed ID: 23430039
[TBL] [Abstract][Full Text] [Related]
3. [The role of adiponectin in the pathogenesis of the metabolic syndrome and approach to therapy].
Rodina AV; Severin SE
Patol Fiziol Eksp Ter; 2013; (1):15-26. PubMed ID: 23805709
[TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in non-alcoholic fatty liver disease.
Tilg H
Dig Dis; 2010; 28(1):179-85. PubMed ID: 20460908
[TBL] [Abstract][Full Text] [Related]
5. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
7. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
Musso G; Gambino R; Cassader M
Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
10. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
12. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease].
Yang H; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Hong Y
Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):525-8. PubMed ID: 17669243
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
Tilg H; Moschen AR
Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
[TBL] [Abstract][Full Text] [Related]
15. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and alcoholic fatty liver disease.
Rogers CQ; Ajmo JM; You M
IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease.
Kaser S; Ebenbichler CF; Tilg H
Int J Clin Pract; 2010 Jun; 64(7):968-83. PubMed ID: 20584230
[TBL] [Abstract][Full Text] [Related]
19. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
20. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
